Medical systems around the world need our help with COVID19. After sharing an important PSA, Kellen dives into the topic of unconventional T cells. These novel immune subsets have unique functions with great therapeutic potential. In this episode, a seminal paper by Michael Crowther and colleagues is discussed. It’s titled, “Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1”.Paper: https://www.ncbi.nlm.nih.gov/pubmed/31959982Review: https://www.ncbi.nlm.nih.gov/pubmed/30397170Please take a few minutes to write us a review wherever you listen to podcasts -- it will help us better spread science!Want to learn more? Check out the Inflammatory Content website www.inflammatorycontent.comFinally, please send any questions or comments to Kellen on Twitter @KellenCavagnero or email [email protected].